About MarqMetrix
MarqMetrix is a Healthcare company based in Seattle (United States) founded in 2012, and was acquired by Thermo Fisher Scientific in June 2023. Raman spectroscopic instruments are manufactured for imaging and detection applications. It operates in the Healthcare and Technology sectors. MarqMetrix has raised $1.04 million across 2 funding rounds from investors including Thermo Fisher Scientific and National Science Foundation. MarqMetrix offers products and services including MarqMetrix All-In-One Process Raman Solution, Cell Culture Media, and Chromatography Columns. Its focus areas include Semiconductors, Photonics, Biophotonics and Analytics and Sensing. Its legal entity is Thermo Fisher Scientific Inc. Its competitors include SpectraWAVE, Ionpath and Impedimed; 3 of its 3 listed competitors have raised funding.
Company details
MarqMetrix was founded in 2012 in Seattle, United States, and operates within the analytical instruments sector. Raman technology is utilized to develop imaging tools and probes for optical measurements, including immersion ball probes based on proprietary methods. The product range encompasses spectroscopy systems, electrochemical measurements, gas calibration equipment, process tools, and analytical instruments. Applications are served across pharmaceuticals, academic research, oil and gas, chemicals, aerospace, and government sectors.
- Headquarters Seattle, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website marqmetrix.com
- Social LinkedIn X Facebook
- Acquired by Thermo Fisher Scientific (Jun 2023)
- Legal Name Thermo Fisher Scientific Inc.
- Total Equity Funding$1.04M (USD)
in 2 rounds
- Latest Funding Round$1.04M (USD), Seed
Sep 2017
- InvestorsThermo Fisher Scientific
& 1 more
- Acquired byThermo Fisher Scientific
(Jun 2023)
Products & Services of MarqMetrix
MarqMetrix offers a comprehensive portfolio of products and services, including MarqMetrix All-In-One Process Raman Solution, Cell Culture Media, and Chromatography Columns.
Provides real-time, non-destructive Raman analysis for process optimization.
Supports cell growth and transfection in research applications.
Facilitates separation and analysis of chemical compounds.
Funding Insights of MarqMetrix
MarqMetrix has successfully raised a total of $1.04M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.04 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.04M
- Total Rounds 2
- Last Round Seed — $1.04M
- First Round $149,567
(Jan 2015)
- Investors Count 1
All 2 funding rounds of MarqMetrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2017 | $1.04M | Seed | – | – | – |
| Jan 2015 | $149,567 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in MarqMetrix
MarqMetrix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for MarqMetrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MarqMetrix
7 people are tracked at MarqMetrix (5 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Giora Proskurowski | Director of Applications & Probes | Leadership |
John Richmond | Director of Sales | Leadership |
Scott Van Vuren | Co-Founder & Chief Operating Officer | Leadership |
Tom Pierson | Chief Financial Officer | Leadership |
Scott Martin | Director of Software Engineering | Leadership |
Aaron Volosin | Software Engineer In Test | Team |
Thomas Dearing | Senior Staff Scientist | Team |
Complete people profiles for MarqMetrix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MarqMetrix
4 dated milestones of MarqMetrix across 11 years, from founding to its latest funding, stage changes and deals.
- Founded MarqMetrix is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Seed, of $1.0M.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of MarqMetrix
MarqMetrix has 3 listed competitors in our database, 3 of them funded. They include SpectraWAVE, Ionpath and Impedimed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| impedimed.com | 1999 | Carlsbad, United States | $3.44M | 76 | Technologies for non-invasive fluid status assessment and monitoring are developed. |
Detailed competitors of MarqMetrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MarqMetrix
The website of MarqMetrix (marqmetrix.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 38.2% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as MarqMetrix (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Marqmetrix
Complete news archive for MarqMetrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MarqMetrix
MarqMetrix was founded in 2012 and raised its 1st funding round 3 years after it was founded.
MarqMetrix is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
MarqMetrix is a funded company, having raised a total of $1.04M across 2 funding rounds to date. The company's 1st funding round was a Grant of $149.57K, raised on Jan 2015.
MarqMetrix was founded in 2012 in Seattle, United States, and operates within the analytical instruments sector. Raman technology is utilized to develop imaging tools and probes for optical measurements, including immersion ball probes based on proprietary methods. The product range encompasses spectroscopy systems, electrochemical measurements, gas calibration equipment, process tools, and analytical instruments. Applications are served across pharmaceuticals, academic research, oil and gas, chemicals, aerospace, and government sectors.
MarqMetrix's top competitors include Ionpath, SpectraWAVE and Impedimed.
MarqMetrix offers MarqMetrix All-In-One Process Raman Solution, Cell Culture Media, and Chromatography Columns.
MarqMetrix has 2 investors. Key investors include Thermo Fisher Scientific, and National Science Foundation.
MarqMetrix operates through Thermo Fisher Scientific Inc..
Yes. MarqMetrix was acquired by Thermo Fisher Scientific in June 2023.